A Study of Gemcitabine ± Erlotinib and DN-101 Versus Gemcitabine ± Erlotinib and Placebo in Patients With Advanced Pancreatic Cancer
This study has suspended participant recruitment.
(DSMB)
Sponsor:
Novacea
Collaborator:
Schering-Plough
Information provided by:
Novacea
ClinicalTrials.gov Identifier:
NCT00536770
First received: September 26, 2007
Last updated: November 2, 2007
Last verified: November 2007
- Full Text View
- Tabular View
- No Study Results Posted
- Disclaimer
- How to Read a Study Record
No Study Results Posted on ClinicalTrials.gov for this Study
| Study Status: | This study has suspended participant recruitment. |
|---|---|
| Estimated Study Completion Date: | No date given |
| Estimated Primary Completion Date: | No date given |